Seegene Inc

Not Available for sale in the United States

  • Conventional
  • Research
    Use Only

H. pylori-ClaR ACE Detection

Detection of two mutations (A2143G and A2142G) causing clarithromycin-resistance

Seeplex® H. pylori-ClaR ACE Detection simultaneously detects and identifies two types of point mutations (A2143G and A2142G) causing clarithromycin-resistance in Helicobacter pylori from direct examination of gastric biopsy tissue without going through bacterial culture. Based on DPO™ technology, this assays performs on PCR instruments and applicable for Auto-capillary Electrophoresis instruments.



1H. pylori
2H. pylori, A2143G
3H. pylori
4H. pylori, A2143G
5H. pylori, A2142G
6H. pylori, A2143G
7H. pylori, A2142G
8H. pylori

1~8: Clinical samples


- Usefulness of Dual Priming Oligonucleotide-Polymerase Chain Reaction for Diagnosis and Treatment of Helicobacter pylori

- Mechanisms of Helicobacter pylori antibiotic resistance and molecular testing

- Dual-priming oligonucleotide-based multiplex PCR using tissue samples in rapid urease test in the detection of Helicobacter pylori infection

- Eradication of Helicobacter pylori according to 23S ribosomal RNA point mutations associated with clarithromycin resistance

- Clarithromycin-resistant Helicobacter pylori associated with 23S rRNA point mutations in Jeju Island

- DPO multiplex PCR as an alternative to culture and susceptibility testing to detect Helicobacter pylori and its resistance to clarithromycin.

- A comparison analysis on the diagnosis of Helicobacter pylori infection and the detection of clarithromycin resistance according to biopsy sites

- Dual-Priming Oligonucleotide-Based Multiplex PCR for the Detection of Helicobacter pylori and Determination of Clarithromycin Resistance with Gastric B